Windlas Biotech Ltd - WINDLAS BIOTECH Share Price

Sector: Pharmaceuticals | ISIN: INE0H5O01029
₹ 503.00 (-1.82%) icon28 Feb, 2024, 1:39:54 PM
Open
₹ 512.30
Prev. Close
₹ 512.30
Turnover(lac)
₹ 0.01
Day's High
₹ 515.95
Day's Low
₹ 495.20
52 Wk High
₹ 583.50
52 Wk Low
₹ 220.55
Book Value
₹ 213.38
Face Value
₹ 5.00
Mkt. Cap (Cr.)
₹ 1,046.17
P/E
20.22
EPS
25.31
Div. Yield
0.79

Windlas Biotech Ltd KEY RATIOS

sector: Pharmaceuticals

  • CMP

    as on 2/28/2024 1:39:54 PM

    ₹ 503 -9.30 -1.82
  • Open
  • ₹ 512.3
  • Prev. Close
  • ₹ 512.3
  • Turnover(Lac.)
  • ₹ 552
  • Day's High
  • ₹ 515.95
  • Day's Low
  • ₹ 495.2
  • 52 Week's High
  • ₹ 583.5
  • 52 Week's Low
  • ₹ 220.55
  • Book Value
  • ₹ 213.38
  • Face Value
  • ₹ 5
  • Mkt Cap (₹ Cr.)
  • 1,046.17
  • P/E
  • 20.22
  • EPS
  • 25.31
  • Divi. Yield
  • 0.79

Windlas Biotech Ltd Corporate Actions

30 Jan , 2024

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Jan , 2024

12:00 AM

30 Oct , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

30 Oct , 2023

12:00 AM

16 Aug , 2023

12:00 AM

AGM

Announcement date: 16 Aug , 2023

View Details

05 May , 2023

12:00 AM

Dividend

Dividend amount: 4
Announcement date: 05 May , 2023

View Details

31 Jul , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

31 Jul , 2023

12:00 AM

28 Apr , 2023

12:00 AM

Board Meeting

Agenda: Audited Results

View Details

17 Aug , 2023

12:00 AM

BookCloser

View Details

Windlas Biotech Ltd News and Update

Image not found
  • 1 day ago |
  • 12:13 AM

A press release issued by One97 Communications Ltd highlighted the appointment of several new members to the PPBL Board

Image not found
  • IIFL News Service |
  • 23 February, 2024 |
  • 12:07 AM
Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM
Image not found
  • IIFL News Service |
  • 22 February, 2024 |
  • 12:06 AM

Invest wise with Expert advice

mobile icon
  • Open Demat with exclusive Advice & Services
  • Get a dedicated Relationship Manager to help you grow your wealth
  • Exclusive advisory on 20+ trading & wealth based investment options
  • One tap Investments, Automated trading & much more
  • Minimum 1 lakh margin required

Windlas Biotech Ltd SHAREHOLDING SNAPSHOT
28 February , 2024 | 02:00 PM

PROMOTER - TOTAL62.82%

Indian: 62.82%

Foreign: 0%

NON-PROMOTER - TOTAL 37.18%

Institutions: 13.06%

Non-Institutions: 24.12%

CUSTODIES - 0.00%

Custodies: 0.00%

See More Details
ad IconAd Image

Windlas Biotech Ltd FINANCIALS

Windlas Biotech Ltd PEER COMPARISON

Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in ₹ Cr.View All Peer Comparison

MORE ABOUT Windlas Biotech Ltd

  • Vivek Dhariwal
  • Chairman & Independent Directo
  • Ashok Kumar Windlass
  • Whole-time Director
  • Hitesh Windlass
  • Managing Director
  • Manoj Kumar Windlass
  • Joint Managing Director
  • Pawan Kumar Sharma
  • Executive Director
  • Prachi Jain Windlass
  • Non-Exec & Non-Independent Dir
  • Srinivasan Venkataraman
  • Non-Exec. & Independent Dir.
  • Gaurav Gulati
  • Non-Exec. & Independent Dir.
  • Ananta Narayan Panda
  • Company Sec. & Compli. Officer

Summary

Windlas Biotech Ltd (formerly known as Windlas Biotech Private Limited) was incorporated in the year 2001. The Company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world.The company has state-of-the-art manufacturing plant facilities located in Dehradun, Uttarakhand, India. It also has a sales force and distribution network spread across 14 states. The company market its own manufactured authentic nutraceutical, pharmaceutical and Ayurvedic products to serve the semi-urban and rural communities at affordable prices. Apart from this, the company has three distinct strategic business verticals (SBVs) mainly comprising of CDMO services and products; domestic trade generics and over-the-counter (OTC) brands; and exports.The company provides a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices (GMP) with a focus on improved safety, efficacy and cost. In addition to this, it sells its own branded products in the trade generics and OTC markets as well as export generic products to several countries. Moreover, the company has significant experience in developing and manufacturing generic fixed dose combinations. Its focus has currently been in launching new complex generic products in... Read More


Reports by Windlas Biotech Ltd


Reports by Windlas Biotech Ltd

Company FAQ

No Record Found